These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10557578)

  • 1. First Amendment limits on regulating information: an initial reaction to the Washington Legal Foundation case.
    Gibbs JN
    Food Drug Law J; 1998; 53(4):597-601. PubMed ID: 10557578
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA marketing v. First Amendment: Washington Legal Foundation legal challenges to off-label policies may force unprecedented changes at FDA.
    Kamp J; Troy DE; Alexander E
    Food Drug Law J; 1999; 54(4):555-65. PubMed ID: 11824453
    [No Abstract]   [Full Text] [Related]  

  • 3. "It's time to make a good agency better": the Food and Drug Administration Modernization Act of 1997 and the First Amendment.
    Murphy AM
    Food Drug Law J; 1998; 53(4):603-25. PubMed ID: 10557579
    [No Abstract]   [Full Text] [Related]  

  • 4. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
    Basile EM; Gross M
    Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
    [No Abstract]   [Full Text] [Related]  

  • 5. The WLF case thus far: not with a bang, but a whimper.
    Cooper RM
    Food Drug Law J; 2000; 55(4):477-89. PubMed ID: 12025847
    [No Abstract]   [Full Text] [Related]  

  • 6. A global view of the First Amendment constraints of FDA.
    Carver KH
    Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
    Cohen MN
    Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
    [No Abstract]   [Full Text] [Related]  

  • 8. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 9. Smoking and the First Amendment.
    Outterson K
    N Engl J Med; 2011 Dec; 365(25):2351-3. PubMed ID: 22149735
    [No Abstract]   [Full Text] [Related]  

  • 10. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ
    Food Drug Law J; 1996; 51(2):323-9. PubMed ID: 11822325
    [No Abstract]   [Full Text] [Related]  

  • 11. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN; Ferrari PL; Murphy AM;
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract]   [Full Text] [Related]  

  • 12. Surfing the Net in shallow waters: product liability concerns and advertising on the Internet.
    Moberg MA; Wood JW; Dorfman HL
    Food Drug Law J; 1998; 53(2):213-24. PubMed ID: 10346682
    [No Abstract]   [Full Text] [Related]  

  • 13. Off-label promotion: is FDA's final guidance on industry-supported scientific and educational programs enforceable?
    Bass IS; Kalb PE; Berenson BA
    Food Drug Law J; 1998; 53(2):193-212. PubMed ID: 10346681
    [No Abstract]   [Full Text] [Related]  

  • 14. The Food and Drug Administration's regulation of prescription drug manufacturer speech: a First Amendment analysis.
    Evans GW; Friede AI;
    Food Drug Law J; 2003; 58(3):365-437. PubMed ID: 14626984
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification and consumer information: modern biotechnology and the regulation of information.
    Beales JH
    Food Drug Law J; 2000; 55(1):105-17. PubMed ID: 12322718
    [No Abstract]   [Full Text] [Related]  

  • 16. The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
    Kahan JS; Shapiro JK
    Food Drug Law J; 2003; 58(3):353-64. PubMed ID: 14626983
    [No Abstract]   [Full Text] [Related]  

  • 17. The case for a substantial evidence amendment to the informal rulemaking provision of the Federal Food, Drug, and Cosmetic Act.
    Bachrach EE
    Food Drug Law J; 2000; 55(3):293-9. PubMed ID: 11824461
    [No Abstract]   [Full Text] [Related]  

  • 18. Health care law.
    Mayo TW
    SMU Law Rev; 2003; 56(3):1767-82. PubMed ID: 12924424
    [No Abstract]   [Full Text] [Related]  

  • 19. The Citizens Internet Empowerment Coalition (CIEC).
    Kmec M
    Natl Netw; 1997 Apr; 21(4):30. PubMed ID: 10166620
    [No Abstract]   [Full Text] [Related]  

  • 20. Inconsistent government policies: why FDA off-label regulation cannot survive First Amendment review under Greater New Orleans.
    Hall RF; Sobotka E
    Food Drug Law J; 2007; 62(1):1-48. PubMed ID: 17444025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.